Simply Oncology

Send us Fan Mail Join us as we finish our discussion on managing menopause in gynaecological cancers with the wonderful Shibani Nicum. Shibani works as as Associate Professor in Medical oncology treating gynaecological cancers at UCL Hospitals London. Shibani helped se up the meno.pause app in conjunction with the British Menopause Society to help guide clinical teams to support patients with meno...

Send us Fan Mail Menopause in Gynae Cancer patients is a major issue. If you struggle when to advise patients in this space. Join us  as we discuss management of menopause in gynae cancer patients with excellent Dr Shibani Nicum from UCL hospitals London. Menopause across all cancer affects up to 60000 patients per year! In Gynae cancers such as ovarian cancer we can make someone menopausal immedi...

Send us Fan Mail Join us for this special episode where we look at the recent major changes in the Platinum resistant ovarian cancer space . For so long this has been a treatment area with limited options  and poor outcomes. Now we have ; - New Drugs - New targets - Better outcomes So much to discuss.  We talk to the brilliant Dr Rowan Miller who specialises in gynaecological cancers and is based...

Send us Fan Mail Join us as we return with the wonderful Professor Mark Beresford from United Hospitals in Bath. We discuss how we as clinicians describe risk to our patients ans we look at some of the pitfalls of using relative risk, overcomplicated statistics with our patients. If we cannot explain risk to patients how can they ,make informed decisions. Mark moves into 'T-shirt Territory&ap...

Send us Fan Mail Join us as we return to our discussion on the fascinating ADePT trial in Glioblastoma brain tumours with the wonderful Dr Faye Robertson from the Western General Hospital, Edinburgh. We discuss how TGX-007 developed with TROGENIX with its super enhancers, dual payload and delivery system hopes to bring a break through in High grade Gliomas. We talk about how could this technology...

Send us Fan Mail Sometimes we hear about a vision for a trial that is so novel and exciting that it takes you back a bit. This is one such moment. Join us as we talk to the amazing Dr Faye Robertson from the Edinburgh cancer Centre about the ingenious ADePT trial. DUAL PAYLOAD GENE THERAPY. Led by Trogenix and the University of Edinburgh, it tests a breakthrough "Trojan horse" gene thera...

Send us Fan Mail We return to discuss the role of radiotherapy in the management of Pancreatic Cancer. What are the side effects of pancreatic radiotherapy and SABR? Do we need an MR Linac to deliver pancreatic SABR Where might pancreatic RT sit alongside new RAS inhibitor therapies? Enjoy

Send us Fan Mail Today we are talking about the role of radiotherapy in Pancreatic Cancer with the superb Dr Ganesh Radhakrishna from the Christie Hospital in Manchester. Radiotherapy may play an increasing role in pancreatic cancer. Stereotactic ablative body radiotherapy (SABR) is helping to get excellent control rates in localised pancreatic cancer and may play a role alongside surgery in pancr...

Send us Fan Mail Join us as we talk to Annie Anderson to get a patient view on advanced kidney cancer and its treatment. Annie was diagnosed with stage IV Kidney Cancer in 2022 which had spread to liver, bone, brain. She went from climbing and running 18 miles to struggling to function. She describes the choices she made and how immunotherapy with has controlled her cancer and allowed her to conti...

Send us Fan Mail Join us as we complete our tour of the adjuvant kidney cancer treatment space. We are joined again by the excellent Dr Will Ince from Cambridge and Dr Naveen Vasudev from Leeds! In our last episode we discussed KEYNOTE 564 and the RAMPART study and where this places immunotherapy in adjuvant kidney cancer. In this episode we discuss the LITESPARK 022 trial and the addition of Belz...

Send us Fan Mail Joins us as we celebrate 100 episodes in style!! In the first of our 2 part special we tackle the Adjuvant Treatment Landscape in Kidney Cancer. We talk to Dr Will Ince from Addenbrookes Hospital Cambridge and Dr Naveen Vasudev from St James’s Hospital Leeds. We discuss the arrival of immunotherapy with the KEYNOTE 564 trial. We discuss the importance of the RAMPART study and back...

Send us Fan Mail Welcome back for Part 2 of our Early Melanoma series with Dr Toby Talbot. We dive in to the potential side effects of treatment and how this affects decisions about adjuvant treatment. We hear about adjuvant BRAF targeted therapy, with more side effects but temporary ones. We look at the future with the NADINA trial for neoadjuvant immunotherapy in high risk clinical stage III dis...

Send us Fan Mail We welcome back our very own Dr Toby Talbot Consultant Clinical Oncologist at Royal Cornwall Hospital for his patient-focussed insights into managing early stage melanoma. In this two part series, we explore what melanoma is, why it comes about and how it is investigated. We discuss surgery, why this might be a two stage procedure and the importance of sentinel lymph node biopsy. ...

Send us Fan Mail Join us for something a bit different this week!! We though it would be fun ( and hopefully helpful) to make an A to Z of Oncology. Are you a patient or care who is newly diagnosed with cancer. Are you new to working around cancer care. Are you in training and want to learn more. Indeed- are you in cancer care and want to know why we have chosen our A to Z. We get the super experi...

Send us Fan Mail Join us as we tackle the topic of Artificial intelligence in Radiotherapy. This week we speak to the excellent Professor Ajay Aggarwal about the use of AI in radiotherapy planning. We discuss the international ARCHERY trial using an AI radiotherapy planning tool to  streamline radiotherapy planning in prostate, head & neck and cervical cancers.  This PRA artificial planning to...

Send us Fan Mail 🎙️New Simply Oncology Podcast to complete our PSMA Lutetium in #ProstateCancer 🎙️Join us for the Part 2 of our masterclass with the superb Dr Amy Eccles ⭐️ As we focus on #ProstateCancerAwarenessMonth we look at future directions for PSMA Lutetium in Prostate Cancer. The British Nuclear Medicine Society are having there annual conference this week. Molecular radiation may offer a...

Send us Fan Mail PSMA Lutetium has been in the background for metastatic prostate cancer for several years. Joins us as we discuss this exciting treatment in metastatic prostate cancer with the excellent Dr Amy Eccles who works at Imperial Hospital London and also the London Clinic. Amy is a radiologist who delivers PSMA Lutetium at the London Clinic and shares her experience with us. Attaching Lu...

Send us Fan Mail Late effects after pelvic radiotherapy part 2. Join us as we complete our conversation with the wonderful Macmillan Late effects consultant radiographer Lisa Durrant. Last week we discussed late bladder and bowel effects from radiotherapy. In this weeks episode we discuss; - hyperbaric oxygen therapy  - pelvic floor exercises - pain as a late effect of radiotherapy - sexual functi...

Send us Fan Mail Join us as we discuss the impact of Pelvic Radiation Disease & the late effects of radiotherapy in the pelvis. We re always trying to get he best result for our patients and to cure cancer but we need to take time to deal with the impact of radiotherapy side effects in our patients. We are talking radiotherapy for pelvic cancers; bladder, prostate, gynaecological and rectal ca...

Send us Fan Mail Join us as return to our excellent conversation on biomarkers in kidney cancer with the wonderful Professor Laurence Albiges from Paris. 🎙️We finish our overview of Biomarkers in metastatic Kidney Cancer with the superb Professor Laurence Albiges from the Gustave Roussy  Hospital in Paris 🇫🇷 Which biomarker will help us to decide which treatment to select in metastatic #KidneyCanc...

Send us Fan Mail Join us for a special Kidney Cancer treat!!! A Must Listen episode!! We discuss the role of biomarkers in advanced kidney cancer with the wonderful Professor Laurence Albiges from the Gustave Roussy Institute of Oncology in Paris. No Kidney Cancer talk is complete without the question -" Where are we with biomarkers ?" This is part 1 of a 2 part walkthrough of the biomar...

Send us Fan Mail Join us is as we celebrate Kidney Cancer week with a Masterclass walk through metastatic Renal Cancer with Professor Ricky Frazer from Velindre Cancer Centre. Ricky is a co-host of the hugely successful Immunobuddies podcast and has a vast experience in immunotherapy management. We look at the indications for immunotherapy versus anti-VEGF TKI therapy. Should we just accept anti-V...

Send us Fan Mail Join us as we return to complete our run through the landscape of metastatic renal cancer with the effervescent Professor Ricky Frazer. We look at the Dolly Mixture of subtypes that makes up non clear cell renal carcinoma. We discuss the new HIF2a inhibitors such as belzutifan. We look at future directions in kidney cancer. A treat for anyone who treats kidney cancer. Enjoy!

Send us Fan Mail Join us for Part 2 of our Metastatic Endometrial Cancer special with the amazing Dr Gemma Eminowicz from University College London Hospital.  In episode 1 we looked at molecular profiling and immunotherapy. In this episode we explore the role of; - hormone therapy - Antibody drug conjugates - PARP inhibitors Endometrial cancer is taking off in terms of new and exciting treatment o...

Send us Fan Mail Dr Gemma Eminowicz returns for 2026!! Join us as we discuss the metastatic endometrial cancer landscape with Simply Oncology 'friend of the show' Dr Gemma Eminowicz from University College Hospital London. Advanced endometrial cancer is so much more than carboplatin and paclitaxel. It now has the complete range of oncological treatments; - Chemotherapy - Immunotherapy -...